|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(1) Pulmonary Department and (2) Research Unit, Hospital La Candelaria, Tenerife and (4) Pulmonary Department, Hospital Miguel Servet, Zaragoza, Spain. (3) Pulmonary Division, Bay Pines VA Medical Center, St Petersburg FL and (5) Pulmonary Division. Caritas-St. Elizabeth's Medical Center, Boston, USA
ccasanova{at}canarias.org
Abstract
RationaleThe distance walked in the 6-minute walk test (6MWT) predicts mortality in patients with severe COPD. Little is known about its prognostic value in patients with a wider range of COPD severity, living in different countries and the potential additional impact of oxygen desaturation measured during the test.
MethodsWe enrolled 576 stable COPD outpatients in Spain and the United States of America, and followed them for at least three years (median 60 months). We measured FEV1, BMI, PaO2, the Charlson co-morbidity score and distance walked (6MWD) and O2 saturation (SpO2) during the 6MWT. Desaturation was defined as a fall in SpO2
4% or Sp02 <90%. Regression analyses helped determine the association between these variables and all cause and respiratory mortality.
ResultsThe 6MWD was a good predictor of all-cause and respiratory mortality primarily in patients with FEV1 <50% (p <0.001) after adjusting for all the co-variates. Patients who desaturated during the 6MWT had a higher mortality than patients who did not desaturate (67% vs 38%, p <0.001). Oxygen desaturation predicted mortality (RR 2.63; 95%CI: 1.53-4.51, p <0.001), but with less power than PaO2 at rest.
ConclusionsThe 6MWD helps predict mortality primarily in patients with severe COPD. Although the oxygen desaturation profile during the 6MWT improves the predictive ability of the 6MWD, it appears to be of less relevance than in other lung diseases and than the resting PaO2.
Key Words: COPD 6-minute walk test long-term mortality
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |